Cited by 383Reproductive tract infections researchUrinary Tract Infections ManagementGynecological conditions and treatments

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

Open access

Cohen, Craig R., Wierzbicki, Michael R., French, Audrey L., Morris, Sheldon, Newmann, Sara, Reno, Hilary, Green, Lauri, Miller, Steve, Powell, Jonathan, Parks, Thomas, Hemmerling, Anke·2020·New England Journal of Medicine

DOI 10.1056/nejmoa1915254PMC PMC7362958

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Bacterial vaginosis affects 15 to 50% of women of reproductive age, and recurrence is common after treatment with an antibiotic agent. The high incidence of recurrence suggests the need for new treatments to prevent recurrent bacterial vaginosis. METHODS: CTV-05 (Lactin-V) to prevent the recurrence of bacterial vaginosis. Women 18 to 45 years of age who had received a diagnosis of bacterial vaginosis and who had completed a course of vaginal metronidazole gel as part of the eligibility requirements were randomly assigned, in a 2:1 ratio, to receive vaginally administered Lactin-V or placebo for 11 weeks; follow-up occurred through week 24. The primary outcome was the percentage of women who had a recurrence of bacterial vaginosis by week 12. RESULTS: CTV-05 was detected in 79% of participants in the Lactin-V group. The percentage of participants who had at least one adverse event related to Lactin-V or placebo by week 24 did not differ significantly between the groups. The percentage of participants with local or systemic adverse events was similar in the two groups. CONCLUSIONS: The use of Lactin-V after treatment with vaginal metronidazole resulted in a significantly lower incidence of recurrence of bacterial vaginosis than placebo at 12 weeks. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT02766023.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1915254

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Inference and missing data
RUBIN, D. B. (1976) · Biometrika · doi:10.1093/biomet/63.3.581 · Cited by 9,925
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,332
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.
Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B. M., Sibeko, S., Mlisana, K. P., Omar, Z., et al. (2010) · Science · doi:10.1126/science.1193748 · Cited by 2,435
Nonspecific vaginitis
Amsel, R., Totten, P. A., Spiegel, C. A., Chen, K. C. S., Eschenbach, D. A., & Holmes, K. K. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91112-9 · Cited by 2,412
A Case–Control Study of Chorioamnionic Infection and Histologic Chorioamnionitis in Prematurity
Hillier, S. L., Martius, J., Krohn, M. A., Kiviat, N. B., Holmes, K. K., & Eschenbach, D. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191503 · Cited by 988
Vaginal Lactobacilli, Microbial Flora, and Risk of Human Immunodeficiency Virus Type 1 and Sexually Transmitted Disease Acquisition
Martin, H., Richardson, B. A., Nyange, P. M., Lavreys, L., Hillier, S. L., Chohan, B. H., Mandaliya, K. N., Ndinya‐Achola, J. O., Bwayo, J., & Kreiss, J. K. (1999) · The Journal of Infectious Diseases · doi:10.1086/315127 · Cited by 884
Cervicovaginal Bacteria Are a Major Modulator of Host Inflammatory Responses in the Female Genital Tract
Anahtar, M. N., Byrne, E. H., Doherty, K. E., Bowman, B. A., Yamamoto, H. S., Soumillon, M., Padavattan, N., Ismail, N., Moodley, A., Sabatini, M. E., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.019 · Cited by 814
High Recurrence Rates of Bacterial Vaginosis over the Course of 12 Months after Oral Metronidazole Therapy and Factors Associated with Recurrence
Bradshaw, C. S., Morton, A. N., Hocking, J. S., Garland, S. M., Morris, M. B., Moss, L. M., Horvath, L. B., Kuzevska, I., & Fairley, C. K. (2006) · The Journal of Infectious Diseases · doi:10.1086/503780 · Cited by 793
Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women
Gosmann, C., Anahtar, M. N., Handley, S. A., Farcasanu, M., Abu-Ali, G., Bowman, B. A., Padavattan, N., Desai, C., Droit, L., Moodley, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.013 · Cited by 696

Flagged first, then by citations

Show all 45 references

Sorted by citations

Items 301–383 of 383

Response to antibiotic treatment of bacterial vaginosis predicts the effectiveness of LACTIN-V ( Lactobacillus crispatus CTV-05) in the prevention of recurrent diseasePreprint
Hemmerling, A., Wierzbicki, M. R., Armstrong, E., & Cohen, C. R. (2023) · medRxiv · doi:10.1101/2023.10.19.23297283
Self-citation
Die Rolle des Mikrobioms in der Reproduktionsmedizin
Oberle, A. (2023) · Springer eBooks · doi:10.1007/978-3-662-63907-8_15
Mixed vaginitis: clinical recommendations regarding presentation, diagnosis and treatmentPreprint
Qi, W., Li, H., Wang, C., Li, H., Zhang, B., Dong, M., Fan, A., Han, C., & Xue, F. (2024) · doi:10.22541/au.170667109.93446480/v1
Insights Into Bacterial Vaginosis
Daroch, P., Sehgal, A., Gupta, V., & Kaur, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13320-6.00024-x
Additional file 6 of Modeling the temporal dynamics of cervicovaginal microbiota identifies targets that may promote reproductive health
Munoz, A. R., Hayward, M. R., Bloom, S. M., Rocafort, M., Ngcapu, S., Mafunda, N. A., Xu, J., Xulu, N., Dong, M., Dong, K. L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15058288
An in silico framework for the rational design of vaginal probiotic therapyPreprint
Lee, C. Y., Bonakdar, S., & Arnold, K. B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.10.588978
Update zur bakteriellen Vaginose
Farr, A., Hoyme, U. B., Jückstöck, J., Mendling, W., & Arbeitsgemeinschaft für Infektionen und Infektionsimmunologie in der Gynäkologie und Geburtshilfe (AGII), D. Z. F. I. I. G. U. G. (2024) · Die Gynäkologie · doi:10.1007/s00129-024-05223-z
A Novel Approach for Reducing Catheter Associated Urinary Tract Infections in Intermittent Catheter UsersPreprint
Sarangapani, S., & Hopke, K. (2024) · Preprints.org · doi:10.20944/preprints202408.0673.v1
Microbiota vaginal y su impacto en las infecciones vaginales a nivel mundial
Hoppe, A. N. Z., Rodríguez, M. A. A., Briggitte, B. R. S., & Beltron, J. E. C. (2024) · Revista Científica de Salud BIOSANA · doi:10.62305/biosana.v4i4.236
Microbiological investigation of pregnancies following vaginal radical trachelectomy using 16S rRNA sequencing of FFPE placental specimens
Tsunematsu, R., Mariya, T., Umemoto, M., Ogawa, S., Arai, W., Tanaka, S. E., Ashikawa, K., Kubo, T., Sakuraba, Y., Baba, T., et al. (2024) · FEBS Open Bio · doi:10.1002/2211-5463.13892
The Vaginal Microbiome: Setting the Stage for Cancer?
Doster, R. S. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae534
Novel Vaginal Microbial Treatments
Wrønding, T., Nielsen, H. S., & Vomstein, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21477-6.00317-5
Das Mikrobiom in der Reproduktionsmedizin: Bedeutung und therapeutische Ansätze
Vomstein, K., & Kuon, R. (2024) · Die Gynäkologie · doi:10.1007/s00129-024-05320-z
Probiotics as a Preventive Strategy for Recurrent Bacterial Vaginosis: A Narrative Review
Valverde, J. A., Fernández, M. L. A., Mora, M. L. A., Alvarado, M. J. A., & Navarro, P. V. (2025) · Cureus · doi:10.7759/cureus.89764 · Cited by 2
Microbiota effects and predictors of Lactobacillus crispatu s colonization after treatment with a vaginal live biotherapeutic: results from a randomized, double-blinded, placebo-controlled trialPreprint
Bloom, S. M., Symul, L., Elsherbini, J., Xu, J., Hussain, S., Shih, J. B., Sango, A., Mitchell, C. M., Hemmerling, A., Parks, T., et al. (2025) · medRxiv · doi:10.1101/2025.08.18.25333897
Self-citation
Host-microbe interactions characterized by gene expression of cervical adhesion molecules, cytokines, and growth factors define the recurrence of bacterial vaginosisPreprint
Klatt, N. R., Swanson, E., Broedlow, C. A., Cherenack, E. M., Nogueira, N. F., Basting, C. M., Yue, P., Chakrawarti, A., Schroeder, T. A., Salazar, A. S., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7576831/v1 · Cited by 1
Synergistic therapeutic effects of endolysin BNT331 and a Lactobacillus crispatus consortium in a human vagina chip model of bacterial vaginosisPreprint
Gulati, A., Jorgenson, A. C., Williams, A., Rhbiny, H., Tisakova, L. P., Corsini, L., Fazel-Zarandi, M., Xu, J., Elsherbini, J., Gutzeit, O., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.05.686849 · Cited by 1
The role of the urinary microbiome in diabetes-associated UTIs: current understanding and future directions
Yathindra, M. R., Badugu, R., Singh, S. P., Paluri, S., Poudala, H., & Swathi, N. L. (2025) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2025-0116
Importance scientifique, sanitaire et sociale du microbiome vaginal
Alizon, S., & Tamarelle, J. (2025) · médecine/sciences · doi:10.1051/medsci/2025139
Multiomic analysis reveals that polyamines alter G. vaginalis -induced cervicovaginal epithelial cell dysfunctionPreprint
Anton, L., Kholod, O., Phatate, R., Ferguson, B., Klohonatz, K., Goods, B. A., & Gerson, K. D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.20.689523
Bacterial vaginosis: the role of microbiota and prospects
Satueva, M. M., Lyamin, A. V., Kolsanova, A. V., Zhilkina, M. P., & Alekseev, D. V. (2025) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn18090
Additional file 5 of Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial
Ross, J. D. C., Brittain, C., Anstey Watkins, J., Kai, J., David, M. D., Ozolins, M., Jackson, L., Abdali, Z., Hepburn, T., Griffiths, F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22792877
Additional file 7 of Modeling the temporal dynamics of cervicovaginal microbiota identifies targets that may promote reproductive health
Munoz, A. R., Hayward, M. R., Bloom, S. M., Rocafort, M., Ngcapu, S., Mafunda, N. A., Xu, J., Xulu, N., Dong, M., Dong, K. L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15058291
Additional file 4 of Modeling the temporal dynamics of cervicovaginal microbiota identifies targets that may promote reproductive health
Munoz, A. R., Hayward, M. R., Bloom, S. M., Rocafort, M., Ngcapu, S., Mafunda, N. A., Xu, J., Xulu, N., Dong, M., Dong, K. L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15058282
Additional file 8 of Modeling the temporal dynamics of cervicovaginal microbiota identifies targets that may promote reproductive health
Munoz, A. R., Hayward, M. R., Bloom, S. M., Rocafort, M., Ngcapu, S., Mafunda, N. A., Xu, J., Xulu, N., Dong, M., Dong, K. L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15058294
Additional file 2 of Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial
Ross, J. D. C., Brittain, C., Anstey Watkins, J., Kai, J., David, M. D., Ozolins, M., Jackson, L., Abdali, Z., Hepburn, T., Griffiths, F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22792868
Additional file 3 of Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial
Ross, J. D. C., Brittain, C., Anstey Watkins, J., Kai, J., David, M. D., Ozolins, M., Jackson, L., Abdali, Z., Hepburn, T., Griffiths, F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22792871
Additional file 3 of Vaginal Lactobacillus crispatus persistence following application of a live biotherapeutic product: colonization phenotypes and genital immune impact
Armstrong, E., Hemmerling, A., Miller, S., Huibner, S., Kulikova, M., Crawford, E. D., Castañeda, G. R., Coburn, B. A., Cohen, C. R., & Kaul, R. (2024) · Figshare · doi:10.6084/m9.figshare.26737386
Self-citation
Additional file 4 of Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial
Ross, J. D. C., Brittain, C., Anstey Watkins, J., Kai, J., David, M. D., Ozolins, M., Jackson, L., Abdali, Z., Hepburn, T., Griffiths, F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22792874
Additional file 1 of Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression
Delgado-Diaz, D. J., Jesaveluk, B., Hayward, J. A., Tyssen, D. P., Alisoltani, A., Potgieter, M. G., Bell, L., Ross, E. J., Iranzadeh, A., Allali, I., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20762886
Additional file 2 of Modeling the temporal dynamics of cervicovaginal microbiota identifies targets that may promote reproductive health
Munoz, A. R., Hayward, M. R., Bloom, S. M., Rocafort, M., Ngcapu, S., Mafunda, N. A., Xu, J., Xulu, N., Dong, M., Dong, K. L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15058276
Additional file 1 of Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial
Ross, J. D. C., Brittain, C., Anstey Watkins, J., Kai, J., David, M. D., Ozolins, M., Jackson, L., Abdali, Z., Hepburn, T., Griffiths, F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22792865
Additional file 3 of Modeling the temporal dynamics of cervicovaginal microbiota identifies targets that may promote reproductive health
Munoz, A. R., Hayward, M. R., Bloom, S. M., Rocafort, M., Ngcapu, S., Mafunda, N. A., Xu, J., Xulu, N., Dong, M., Dong, K. L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15058279
Additional file 2 of Vaginal Lactobacillus crispatus persistence following application of a live biotherapeutic product: colonization phenotypes and genital immune impact
Armstrong, E., Hemmerling, A., Miller, S. A., Huibner, S., Kulikova, M., Crawford, E. D., Castañeda, G. R., Coburn, B. A., Cohen, C. R., & Kaul, R. (2024) · Figshare · doi:10.6084/m9.figshare.26082687
Self-citation
Additional file 5 of Modeling the temporal dynamics of cervicovaginal microbiota identifies targets that may promote reproductive health
Munoz, A. R., Hayward, M. R., Bloom, S. M., Rocafort, M., Ngcapu, S., Mafunda, N. A., Xu, J., Xulu, N., Dong, M., Dong, K. L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15058285
Additional file 1 of DNA methylation signatures to predict the cervicovaginal microbiome status
Nene, N. R., Barrett, J. J. E., Jones, A., Evans, I., Reisel, D., Timms, J. F., Paprotka, T., Leimbach, A., Franchi, D., Colombo, N., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13278392
Additional file 1 of Vaginal Lactobacillus crispatus persistence following application of a live biotherapeutic product: colonization phenotypes and genital immune impact
Armstrong, E., Hemmerling, A., Miller, S., Huibner, S., Kulikova, M., Crawford, E. D., Castañeda, G. R., Coburn, B. A., Cohen, C. R., & Kaul, R. (2024) · Figshare · doi:10.6084/m9.figshare.26082586
Self-citation
Additional file 1 of Improvement of vaginal probiotics Lactobacillus crispatus on intrauterine adhesion in mice model and in clinical practice
Wu, F., Kong, Y., Chen, W., Liang, D., Xiao, Q., Hu, L., Tan, X., Wei, J., Liu, Y., Deng, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26576729
Changes in the Genital Microbiome and Inflammation Among Women Using 30-Day L. Rhamnosus/L. Reuteri Probiotic in Combination with Intravaginal Estradiol: Findings from a Pilot, Open-Label, Phase I Clinical TrialPreprint
Dabee, S., Niazy, M., Gill, B., Wessels, J. M., Hayes, C. L., Nazli, A., Ratcliffe, J., Wokuri, J., Reid, G., Kaul, R., et al. (2025) · medRxiv · doi:10.64898/2025.12.03.25341486
Advances in treating bacterial vaginosis: recognizing sexual transmission and pipeline of therapies
Kim, E. S., Waltmann, A., Duncan, J. A., & Hood-Pishchany, M. I. (2025) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000001172 · Cited by 1
Vaginal Lactobacillus postbiotics ameliorate Gardnerella vaginalis -induced bacterial vaginosis by regulating vaginal microbiota and restoring Th17/Treg balance
Zhou, S., Wen, X., & Chu, W. (2026) · Journal of Applied Microbiology · doi:10.1093/jambio/lxag024
Regulatory Effects of Lactobacillus crispatus and Lactobacillus rhamnosus on the Formation and Composition of Gardnerella Biofilms
Qin, H., Liu, Y., Yin, S., Zhai, Z., & Xiao, B. (2026) · Microorganisms · doi:10.3390/microorganisms14030569
Characterisation of vaginal Lactobacillus isolates from South African women towards the development of a biotherapeutic to optimise the vaginal microbiomePreprint
Wilson, J., Hamzah, A. S. A., Jordan, C. K. I., Hayward, J. A., Kullin, B., Manhanzva, M. T., Tyssen, D. P., Mehou‐Loko, C., Abrahams, A. G., Radzey, N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.26.714511
The Metabolic Calibration of Female Immune Plasticity: From X-Linked Vulnerability to Precision Metabotyping
Huang, Z., Ren, J., Shu, Q., Tang, Y., Zhang, J., Yu, W., Zhang, C., Pang, Y., Liu, L., Han, J., et al. (2026) · Biology · doi:10.3390/biology15070558
Immunotherapeutic Applications of Probiotics in Infectious Diseases Management: A Scoping Review
Adejumo, S. A., Ojiako, C. M., Das, P., Onyia, F. C., Okafor, M. N., Chukwuma, I. F., Hampton‐Marcell, J., & Oli, A. N. (2026) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/8197569
Crisping up Lactobacillus vaginal live biotherapeutics
van de Wijgert, J. H. H. M. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.03.014
Epidemiology and management of bacterial vaginosis in Dakar, Senegal
Cisse, A., Niang, M. M., Escola, J., Quioc-Salomon, B., Talbot, C. P. J., & Carrois, F. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04443-w
The Vulvar Microbiome in Children and Adolescents: Developmental Dynamics, Dysbiosis, and Clinical Implications
Herter, L. D., Hakim, J. C.-E., Hildebrand, S. S., Jacobsen, G. E., & Simms-Cendan, J. S. (2026) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-026-00465-1
Complement and neutrophils are actively involved at the cervicovaginal interface in cases of adverse microbial composition, cervical shortening and spontaneous preterm birth
Gimeno-Molina, B., Correia, G. D. S., Ng, S., LEE, Y. S., Bayar, E., Love, R. L., Zhao, S., Mountain, K. E., Teoh, T. G., Brown, R. G., et al. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-00969-x · Cited by 1
Postpartum Pain and Vaginal–Gut Microbiota Interactions: An Integrative Narrative Review with Implications for Maternal Recovery and Pain Modulation
Ding, C., Zhou, J., Zhu, Y., Xie, X., Ye, F., & Ying, S. (2026) · Journal of Pain Research · doi:10.2147/jpr.s600098
Fatty acid auxotrophy as driver of Lactobacillus symbiosis in the female urinary tractPreprint
Neugent, M. L., Dalvi, H., Saenz, C. N., Gauch, J. L., Koonjbearry, N. S., Komarovsky, J., Lim, K. C., Spiro, E., & Nisco, N. J. D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.23.720460 · Cited by 2
Probiotics: An Emerging Tool against Pathogenic Bacteria
Bur, D., Akinola, I. A., Adeleke, A. A., Ezika, E. K., Ezennubia, K. P., Abdul-karim, H., Sulemana, O. I. R., Sulemana, M. M. I., & Rowaiye, A. B. (2026) · European Journal of Biology · doi:10.26650/eurjbiol.2026.1781227
Effectiveness of Non-Antibiotic Therapies in the Management of Recurrent Urinary Tract Infections in Women: A Systematic Review
Munir, A., Tarannum, T., Saad, N., & Abdaal, M. (2026) · International Urogynecology Journal · doi:10.1007/s00192-026-06654-z
Clinical and vaginal microbiota effects of oral Lactobacillus crispatus M247 combined with vaginal laser therapy in menopausal women with atrophic vulvovaginitis: a prospective, randomized and controlled study
Pierro, F. D., Filippini, M., Lucia, M., Khan, A., Ujjan, I., Khan, S. A., Cazzaniga, M., Bertuccioli, A., Sisti, D., Recchia, M., et al. (2026) · Lasers in Medical Science · doi:10.1007/s10103-026-04900-w
Efficacy of Probiotics with Metronidazole Versus Metronidazole Alone for the Treatment of Bacterial Vaginosis
Anwar, S., Janjua, M., Shahzad, Q., Kanwal, S., Tahir, M., & Akmal, N. (2026) · Journal of Pakistan Society of Internal Medicine. · doi:10.70302/jpsim.v7i2.2626
Exploratory pilot study of a spray-type probiotic delivery system for vaginal health in women at risk for bacterial vaginosis
Park, S., Kim, J., You, Y., Hur, Y. M., Jung, Y., Lee, G., Son, D., Lee, H. A., Ha, M. J., & Kim, Y. J. (2026) · Scientific Reports · doi:10.1038/s41598-026-74965-8
Global Probiotic Markets Meet Synthetic Biology: Translational Challenges and Escherichia coli Nissle 1917 as a Model Chassis
Chen, J., Chou, C.-H. P., & Liu, Y. (2026) · Microorganisms · doi:10.3390/microorganisms14061306
Vaginal microbiota transplantation: from microbial transfer to ecological restoration
Ding, T., Zhang, Z., Ning, J., & Yang, J. (2026) · The Lancet Microbe · doi:10.1016/j.lanmic.2026.101475
Difficult-to-Treat Vaginal Infections: Current Best Practices
Harbison, H. S., & Stephens, R. (2026) · Clinical Journal for Nurse Practitioners in Women s Health · doi:10.1891/cjnpwh-2025-0060
Metabolism-Driven Modulation by the Human Microbiota: Implications for Cancer Therapy and Emerging Strategies
Gouveia, L., Serpa, J., & Mendes, C. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_3
Intravesical Lacticaseicillus rhamnosus GG reduces symptoms among people with spinal cord injury and disease who use intermittent catheterization: A randomized comparison of two- and four-dose regimensPreprint
Groah, S. L., Tractenberg, R. E., Riegner, C., & Forster, C. S. (2026) · medRxiv · doi:10.64898/2026.07.17.26358333
The intersection of engineered live biotherapeutics, the microbiome, and drug delivery
Crook, N., & Nguyen, J. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115939
Microbiota and inflammatory factor profiles in different stages of bacterial vaginosis formation and recurrence
Zhu, Q., Li, Y., & Luo, H. (2026) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002183
Unexplained Recurrent Pregnancy Loss and Emerging Endometrial Biology: A Clinically Oriented Narrative Review
Inoue, D. (2026) · Cureus · doi:10.7759/cureus.114105
Rethinking Prevention of Recurrent Bacterial Vaginosis: A Comparative Effectiveness Network Meta-Analysis
Gardella, B., Dominoni, M., Pano, M. R., Lovotti, A., & Spinillo, A. (2026) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000966
An Observational Study of Vaginal Antibacterial Activity and Outcomes After Antibiotic Prescription for Bacterial Vaginosis
Fredricks, D. N., Krantz, E. M., Proll, S. C., Liu, C., Fiedler, T. L., Strenk, S. M., Djukovic, D., Raftery, D., & Srinivasan, S. (2026) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiag412
The Impact of the Vaginal Microbiome and Microbial Metabolites on HIV Transmission at the Female Reproductive Tract Epithelial Barrier
Jesaveluk, B., Ellenberg, P. C., Hearps, A. C., & Tachedjian, G. (2026) · American Journal of Reproductive Immunology · doi:10.1111/aji.70312
Relieving effect of Lactobacillus crispatus RS08 on Candida albicans-induced vaginitis by regulating NF-κB signaling pathway
Yu, X., Ma, X., Zhao, X., & Wang, W. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02417-4
Characterization of vaginal lactobacilli from South African women toward the development of a biotherapeutic to optimize the vaginal microbiome
Wilson, J., Hamzah, A. S. A., Jordan, C. K. I., Hayward, J. A., Kullin, B., Manhanzva, M. T., Tyssen, D. P., Mehou‐Loko, C., Abrahams, A. G., Radzey, N., et al. (2026) · Applied and Environmental Microbiology · doi:10.1128/aem.00566-26
The blurred line between balance and crisis: From vaginal microbiome dynamics and pregnancy health to novel paradigms in managing vaginal dysbiosis
Soleymanpour, K., Mehramuz, B., Taghizadeh, S., Ganbarov, K., Köse, Ş., & Kafil, H. S. (2026) · The Microbe · doi:10.1016/j.microb.2026.100782
Vaginal microbe-binding antibody interactions with a Lactobacillus crispatus live biotherapeutic following treatment for bacterial vaginosis
Liu, R., Armstrong, E., Hemmerling, A., Miller, S. A., Huibner, S., Lagenaur, L. A., Parks, T., Cohen, C. R., Coburn, B. A., & Kaul, R. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03983-25
Self-citation
Predicting bacterial vaginosis incidence using artificial neural networks
Elnaggar, J. H., Lammons, J. W., Ardizzone, C. M., Aaron, K. J., Jacobs, C. D., Graves, K. J., George, S. D., Amerson-Brown, M. H., Luo, M., Tamhane, A., et al. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014768
Probiotics for BV and VVC Treatment and Prevention: An Umbrella Review of Systematic Reviews and Meta-Analyses, with Inclusion of Recent Randomized Controlled Trials
Claassen-Weitz, S., & Happel, A. (2026) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-026-00491-z
Vaginal Lactic Acid and Lactobacillus‐Dominated Microbiota in HIV‐1 Susceptibility: Mechanistic Insights and Implications for Sub‐Saharan African Women
Adamu, A. (2026) · American Journal of Reproductive Immunology · doi:10.1111/aji.70326
Vaginal Lactobacillus paragasseri may attenuate fluconazole-resistant phenotypes in the subset of Candida albicans isolates and shows potential as a probiotic adjunct in antifungal therapy
Wang, Q., Wang, H., Pan, H., Xu, Z., Cui, Q., 赵汇海, Jia, K., & 王缚鲲 (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1951876
Management of Recurrent Vaginitis
Yazdy, G. M., Powell, A. M., & Tuddenham, S. (2026) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2026.08.010
Management of Recurrent Vaginitis
Powell, A. M., Sobel, J. D., & Muzny, C. A. (2026) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-026-00494-w
Transmission of lactic acid bacteria: a case study of the human vaginal microbiome
Erreygers, I., Pinedo-Bardales, M., Dey, H., Segata, N., Wittouck, S., Lebeer, S., & Heidrich, V. (2026) · Current Opinion in Microbiology · doi:10.1016/j.mib.2026.102845
Engineered live biotherapeutic products: design decisions, failure modes, and clinical translation
Shen, S., Zhao, J., & Gao, H. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.2002085
Maternal iron deficiency, preterm birth, and disrupted microbial inheritance: a proposed double-hit hypothesis
Khan, F. Z. A., & Ali, S. A. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1953925
Direct on-swab metabolic profiling of vaginal microbiome host interactions
MacIntyre, D. (2022) · ImmPort · doi:10.21430/m3zxhxs7fv
A translational-readiness framework for natural and engineered probiotics
Hribernik, N., Maan, H., & Povolotsky, T. L. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1965075
Towards a sequential microbiome therapy for HPV-associated cervicovaginal dysbiosis
Molina, M. A., Zhang, Y., Steenbergen, R. D. M., Melchers, W. J. G., & Du, J. (2026) · Communications Biology · doi:10.1038/s42003-026-11208-6

Authors: Cohen, C. R., Wierzbicki, M. R., French, A. L., Morris, S., Newmann, S., Reno, H., Green, L., Miller, S., Powell, J., Parks, T., & Hemmerling, A.
Affiliations: University of California, San Francisco (US)
Rush University Medical Center (US)
ORCID: Cohen, Craig R.
French, Audrey L.
Newmann, Sara
Reno, Hilary
Green, Lauri
Miller, Steve
Parks, Thomas
Hemmerling, Anke
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2020-05-14
Volume: 382
Issue: 20
Pages: 1906-1915
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1915254
PMC: PMC7362958
OpenAlex: W3024851520
Cited by: 377
References: 45
Citations by year: 2026: 71 · 2025: 70 · 2024: 55 · 2023: 60 · 2022: 47 · 2021: 52 · 2020: 22
FWCI: 33.29
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.nejmgroup.org/legal/terms-of-use.htm (vor)
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institute of Allergy and Infectious Diseases (HHSN272201300014I/HHSN27200007)
Topics: Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Health Sciences › Medicine › Urology › Urinary Tract Infections Management
Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords: bacterial vaginosis, recurrence prevention, vaginal probiotics, Lactobacillus, metronidazole, vaginal treatment, adverse events
MeSH terms: Lactobacillus crispatus, Administration, Intravaginal, Adolescent, Adult, Antibiosis, Anti-Bacterial Agents, Double-Blind Method, Female, Gels, Humans, Metronidazole, Middle Aged, Vagina, Incidence, Vaginosis, Bacterial, Secondary Prevention, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks